HOLON, Israel, June 3, 2019 /PRNewswire/ — Compugen Ltd. (CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, today announced that its ongoing Phase 1 clinical trial evaluating COM701, a first-in-class therapeutic...
New Clinical Data Presented Today Included in Recently Submitted NDA to FDA Epizyme, Inc. (EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today reported updated data on tazemetostat from the epithelioid sarcoma cohort of its...
A presentation at the ASCO Annual Meeting (June 2, 2019; Chicago, IL) explored the role that the clinical pathways program at the Levine Cancer Institute (Charlotte, NC) plays in clinical trial enrollment. Researchers from Levine Cancer Institute said that clinical...
Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today presented topline results from the pivotal European Phase 3 ARTEMIS clinical trial, which it previously announced had met its...
– Phase II trial evaluating bemcentinib in combination with KEYTRUDA in advanced NSCLC patients shows 12-month survival data surpassing historical benchmarks in second-line treatment with PD-1 inhibitor monotherapy – Promising clinical activity continues...
Clinical trials research develops safe and effective strategies to treat or prevent human disease and provide researchers with new ways to approach medical treatment that can improve or save the lives of patients. Historically, rural populations have been...
Email
Text